Mettler Toledo (MTD)
NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-08
$1248.96-3.60%
Close 2026-07-08 · 1-day change
Reading MTD? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MTD free→NYSEHealth CareDiagnostics & ResearchSnapshot 2026-07-08
Reading MTD? This analysis is rebuilt every market day. Get it tracked free. No credit card.
Track MTD free→Mettler Toledo grows earnings about 8% to 10% in 2026. Sales rise steadily near 4% in local currency. Profit margins stay strong with consistent beats. The company leads in weighing and analytical instruments.
Sales growth lags the 4% target and EPS growth slows below 8%. Rising costs could pressure profit margins. Competition or market softness may hurt demand and earnings.
The price is about 8% above our fair value near $1194. Analysts expect roughly 6% revenue growth, slightly below management's 8-10% EPS growth target. Our fair value is 13% below the Street median, reflecting some valuation caution.
Breaks if: adjusted EPS growth falls below 8% in FY26
Management aims for adjusted EPS growth between 8% and 10% for the fiscal year 2026.
Stated in 3 of last 3 quarters. Adjusted EPS for 2026 is forecast to be between $46.30 and $46.95, indicating growth of 8% to 10%. The company reported adjusted EPS of $8.91 in 2026-Q1, up 9% from $8.19 in 2025-Q1, showing progress towards the target.
Breaks if: local currency sales growth falls below 3% in FY26
Management targets a 4% increase in local currency sales for the fiscal year 2026.
Stated in 3 of last 3 quarters. Local currency sales increased 3% in 2026-Q1 compared to the prior year. Management's target of 4% growth for 2026 shows limited progress so far, with a need to accelerate growth in upcoming quarters.
Breaks if: Spinnaker program expansion stalls or reverses in FY26
Management is focused on expanding the Spinnaker sales and marketing program to drive growth.
Standing thesis, reviewed periodically — not a price target or advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
“Adjusted EPS is forecast to be in the range of $46.30 to $46.95, representing growth of approximately 8% to 10%.”
“Adjusted EPS was $13.36, an increase of 8% over the prior-year amount of $12.41.”
“Adjusted EPS was $10.57, an increase of 6% over the prior-year amount of $9.96.”
“Management anticipates local currency sales for the second quarter of 2026 will increase approximately 3%.”
“Management anticipates local currency sales will increase approximately 4% for the full year 2026.”
“Local currency sales increased 5% compared with the prior year.”